GreenScreen HC and BlueScreen HC
Early accurate screening conducted with GreenScreen® HC or BlueScreen HC™ human (TK6) cell based assays gives rapid results. Both assays use patented gene reporter systems with either Green Fluorescent Protein (GFP) or Gaussia Luciferase (G.Luc) to detect up-regulation of GADD-45a, a key P53 dependant response element in the DNA stress pathway. The assays require only milligram quantities of material and give results in just 48hrs.
In vitro Micronucleus Test
The micronucleus assay detects aberrant, small nuclei present in the cell cytoplasm. Micronuclei may contain whole chromosomes ‘lost’ during mitosis or fragments generated by chromosome breakage.
Flow cytometric assessment permits automated scoring, which removes subjectivity, and rapid measurement of large numbers of cells increases statistical power. In addition, the in vitro MicroFlow® method used by Gentronix allows simultaneous collection of relative survival and membrane integrity parameters for cytotoxicity assessment, as well as cell cycle information.
Ames MPF assay
Ames MPF™ is an adapted microfluctuation method for performing the Ames bacterial mutagenicity test. Hisˉ or Trpˉ tester strains are incubated with test samples and scored for colony growth, indicating reversion to His+ or Trp+ phenotype has occurred.
Can we kill skin cancer cells (the bad guys) without harming normal cells (the good guys)?
Normally we remove cancer with surgery (a doctor cuts it out). This project explores the possibility of using drugs to remove cancer cells.
Drugs designed to affect cellular functions unique to cancer cells are called “targeted therapies”.
We previously compared the genes switched on in skin cancer cells with genes switched on in normal skin cells and identified 2 genes which are important for keeping cancer cells alive.
produces Polo-like kinase-1 which is an enzyme that plays a role in cell division (mitosis). This protein has a known role in maintaining cancer cell survival in cancers from organs other than the skin. As a consequence small molecule inhibitors which bind to the active site of the enzyme have been developed by drug companies. We will test whether skin cancer and normal skin cells are affected by exposing these cells to two inhibitors, BI25436 and GW843682X.
is a gene with unknown function. Eventually my lab wants to develop drugs which target the protein product of this gene but before this can happen we need to know what job it does in the cell. To do this we can introduce DNA which will make the cell produce C20ORF20 protein that has a fluorescent tag attached to it. This fluorescent tag will tell us where the protein goes giving us a clue to what it does in the cell. We will manipulate this DNA and introduce it into skin cells to look at where the protein goes in the cell using fluorescent microscopy.